<DOC>
	<DOCNO>NCT02046083</DOCNO>
	<brief_summary>The primary purpose protocol evaluate efficacy protocol induction tolerance peanut ingestion increase dos . The secondary purpose determine interest prolong maintenance therapy</brief_summary>
	<brief_title>Peanut Oral Induction Tolerance Peanut 's Allergic Teenagers</brief_title>
	<detailed_description>Prospective randomize double blind , placebo control , protocol two phase : 1/ active treatment versus placebo induction phase ; 2/ long versus short maintenance</detailed_description>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<criteria>Adolescents 12 18 year Clinical History allergic manifestation within one hour ingestion peanut DoubleBlind , PlaceboControlled Food Challenges ( DBPCFCs ) peanut positive threshold 2 gram Bad reaction peanut demonstrate positive Patch Test ( PT â‰¥ 3 mm negative control ) specific IgE f13 &gt; 12 IU / mL / rAra h2 &gt; 5.8 IU / mL Previous follow least 1 year Lack response initial DBPCFCs cumulative dose 2 gram peanut instant dose 1 gram peanut Uncontrolled asthma / severe previous year Atopic dermatitis uncontrolled Initial severe anaphylaxis require hospitalization intensive care Presence major allergy anaphylaxis another allergen risk ( milk , egg , nut , ) Home away center could support severe reaction emergency Lack motivation understand parent / child Incapacity establish daily logbook clinical monitoring support severe reaction eat peanut follow regular peanut ingestion protocol</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Teenager</keyword>
	<keyword>Peanut</keyword>
	<keyword>OIT ( Oral Induction Tolerance )</keyword>
</DOC>